Literature DB >> 19262135

The role of PP2A A subunits in tumor suppression.

Anna A Sablina1, William C Hahn.   

Abstract

The protein phosphatase 2A (PP2A) family of heterotrimeric serine-threonine phosphatases participates in human cell transformation. Each functional PP2A complex contains one structural A subunit (A alpha or A beta), and mutations of both are found to occur at low frequency in human tumors. We have shown that A alpha functions as haploinsufficient tumor suppressor gene by regulating in part phosphatidylinositol 3-kinase (PI3K) signaling. In contrast, loss of A beta function due to biallelic alterations contributes to cancer progression through dysregulation of small GTPase RaIA activity. These observations provide evidence that dysfunction of particular PP2A complexes regulate specific phosphorylation event necessary for cancer initiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19262135      PMCID: PMC2634016          DOI: 10.4161/cam.1.3.4986

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  17 in total

1.  Distinct role of protein phosphatase 2A subunit Calpha in the regulation of E-cadherin and beta-catenin during development.

Authors:  J Götz; A Probst; C Mistl; R M Nitsch; E Ehler
Journal:  Mech Dev       Date:  2000-05       Impact factor: 1.882

2.  Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the A beta subunit gene.

Authors:  R Ruediger; H T Pham; G Walter
Journal:  Oncogene       Date:  2001-04-05       Impact factor: 9.867

Review 3.  Ral-GTPases: approaching their 15 minutes of fame.

Authors:  Larry A Feig
Journal:  Trends Cell Biol       Date:  2003-08       Impact factor: 20.808

4.  Identification of specific PP2A complexes involved in human cell transformation.

Authors:  Wen Chen; Richard Possemato; K Thirza Campbell; Courtney A Plattner; David C Pallas; William C Hahn
Journal:  Cancer Cell       Date:  2004-02       Impact factor: 31.743

5.  Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene.

Authors:  R Ruediger; H T Pham; G Walter
Journal:  Oncogene       Date:  2001-01-04       Impact factor: 9.867

6.  Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms.

Authors:  G A Calin; M G di Iasio; E Caprini; I Vorechovsky; P G Natali; G Sozzi; C M Croce; G Barbanti-Brodano; G Russo; M Negrini
Journal:  Oncogene       Date:  2000-02-24       Impact factor: 9.867

7.  Characterization of the Aalpha and Abeta subunit isoforms of protein phosphatase 2A: differences in expression, subunit interaction, and evolution.

Authors:  Jin Zhou; Huong T Pham; Ralf Ruediger; Gernot Walter
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

8.  Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers.

Authors:  Y Takagi; M Futamura; K Yamaguchi; S Aoki; T Takahashi; S Saji
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

Review 9.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

Authors:  V Janssens; J Goris
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

10.  PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers.

Authors:  Masato Tamaki; Takanori Goi; Yasuo Hirono; Kanji Katayama; Akio Yamaguchi
Journal:  Oncol Rep       Date:  2004-03       Impact factor: 3.906

View more
  21 in total

1.  DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontin.

Authors:  A Mitra; M E Menezes; L K Pannell; M S Mulekar; R E Honkanen; L A Shevde; R S Samant
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

2.  PP2A:B56{epsilon}, a substrate of caspase-3, regulates p53-dependent and p53-independent apoptosis during development.

Authors:  Zhigang Jin; Lindsay Wallace; Scott Q Harper; Jing Yang
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

3.  miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA.

Authors:  Francesca Maria Orlandella; Raffaela Mariarosaria Mariniello; Paola Lucia Chiara Iervolino; Esther Imperlini; Annalisa Mandola; Anna Verde; Anna Elisa De Stefano; Katia Pane; Monica Franzese; Silvia Esposito; Fulvio Basolo; Stefania Orrù; Giuliana Salvatore
Journal:  Endocrine       Date:  2019-03-29       Impact factor: 3.633

4.  STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells.

Authors:  Jong Wook Kim; Christian Berrios; Miju Kim; Amy E Schade; Guillaume Adelmant; Huwate Yeerna; Emily Damato; Amanda Balboni Iniguez; Laurence Florens; Michael P Washburn; Kim Stegmaier; Nathanael S Gray; Pablo Tamayo; Ole Gjoerup; Jarrod A Marto; James DeCaprio; William C Hahn
Journal:  Elife       Date:  2020-01-08       Impact factor: 8.140

5.  Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion.

Authors:  Carrie D House; Charles J Vaske; Arnold M Schwartz; Vincent Obias; Bryan Frank; Truong Luu; Narine Sarvazyan; Rosalyn Irby; Robert L Strausberg; Tim G Hales; Joshua M Stuart; Norman H Lee
Journal:  Cancer Res       Date:  2010-07-22       Impact factor: 12.701

6.  Protein phosphatase 2A Aα regulates Aβ protein expression and stability.

Authors:  Caitlin M O'Connor; Matthew T Hoffa; Sarah E Taylor; Rita A Avelar; Goutham Narla
Journal:  J Biol Chem       Date:  2019-02-22       Impact factor: 5.157

Review 7.  The role of adiponectin in cancer: a review of current evidence.

Authors:  Maria Dalamaga; Kalliope N Diakopoulos; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2012-04-30       Impact factor: 19.871

8.  PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality.

Authors:  Eric G Bluemn; Elysia Sophie Spencer; Brigham Mecham; Ryan R Gordon; Ilsa Coleman; Daniel Lewinshtein; Elahe Mostaghel; Xiaotun Zhang; James Annis; Carla Grandori; Christopher Porter; Peter S Nelson
Journal:  Mol Cancer Res       Date:  2013-03-14       Impact factor: 5.852

9.  RalA is overactivated in medulloblastoma.

Authors:  Kevin F Ginn; Ben Fangman; Kaoru Terai; Amanda Wise; Daniel Ziazadeh; Kushal Shah; Robyn Gartrell; Brandon Ricke; Kyle Kimura; Sharad Mathur; Emma Borrego-Diaz; Faris Farassati
Journal:  J Neurooncol       Date:  2016-08-26       Impact factor: 4.130

Review 10.  Role of "oncogenic nexus" of CIP2A in breast oncogenesis: how does it work?

Authors:  Pradip De; Jennifer H Carlson; Brian Leyland-Jones; Nandini Dey
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.